Epizyme, Inc. (EPZM) Social Stream



Epizyme, Inc. (EPZM): $0.51

-0.01 (-2.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EPZM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Epizyme Inc (EPZM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Epizyme Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $15 $5 $10 $1.16 762.07%
2022-01-10 4 $15 $3 $10.5 $1.16 805.17%
2022-01-28 4 $15 $2 $10.25 $1.16 783.62%
2022-03-01 4 $15 $2 $9.25 $1.16 697.41%
2022-03-04 4 $10 $2 $7.25 $1.16 525%

The Trend in the Analyst Price Target


Over the past 18 months, EPZM's average price target has gone down $21.13.

Over the past 114 days, EPZM's average upside potential has been 336.75%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-10 5 15 5 10.00 4.83 107.04%
2021-11-10 5 15 5 11.00 4.83 127.74%
2022-01-10 4 15 3 10.50 2.41 335.68%
2022-01-21 4 15 2 10.25 2.07 395.17%
2022-02-28 4 15 2 9.25 1.49 520.81%

EPZM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 28 days, EPZM's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EPZM has a higher upside potential (average analyst target price relative to current price) than 587.83% of all US stocks.
  • In terms of how Epizyme Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -464.51% of that group.
  • EPZM has a higher average analyst price target than 36.16% of stocks in the mid market cap category.
  • EPZM has a higher number of analysts covering the stock than 104.55% of stocks in the mid market cap category.

Stocks similar to Epizyme Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENTA, EBS, and DVAX.

Is EPZM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7061 seconds.